Email Us:
To contact Trxade, please complete the form below and a team member will reply as soon as possible.
FDA Stay Informed RSS
- FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC August 19, 2019Oncology NewsburstFDA
FiercePharma News RSS
- AbbVie scores blockbuster approval for RA med Rinvoq, its crucial Humira follow-up August 16, 2019The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here. Friday, the FDA greenlighted Rinvoq, a rheumatoid arthritis med meant to succeed best-selling Humira as copycats bite into its sales. The new product should be available in the U.S. by late August, AbbVie said.Carly Helfand